Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call
Rhea-AI Summary
Nephros (Nasdaq: NEPH) will file fourth-quarter 2025 financial results on March 12, 2026 after market close and will host a conference call the same day at 4:30pm ET. Participants can join via domestic and international dial-ins; an audio archive and a replay (through March 19, 2026) will be available on the company's Investor Relations page.
Replay access code: 3018234. Domestic dial-in: 1 (844) 808-7106; international dial-in: 1 (412) 317-5285.
Positive
- None.
Negative
- None.
News Market Reaction – NEPH
On the day this news was published, NEPH gained 1.83%, reflecting a mild positive market reaction. Argus tracked a trough of -4.7% from its starting point during tracking. This price movement added approximately $775K to the company's valuation, bringing the market cap to $43M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
NEPH’s modest -1.29% move came alongside mixed peers: MLSS -2.03%, POCI -1.37%, NXGL -6.73%, while HBIO rose 0.63%, indicating stock-specific trading rather than a clear sector trend.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 30 | Earnings call schedule | Neutral | +1.6% | Set date and time for Q3 2025 results and investor call. |
| Jul 31 | Earnings call schedule | Neutral | -3.7% | Announced Q2 2025 results release and related conference call. |
| Oct 31 | Earnings call schedule | Neutral | +1.4% | Outlined Q3 2024 results release date and 4:30pm ET call. |
| Aug 01 | Earnings call schedule | Neutral | +2.3% | Planned Q2 2024 results filing and investor conference call. |
Scheduling earnings calls has historically led to small, mixed price reactions, with a slight tendency toward positive moves.
Over the past two years, Nephros has regularly announced earnings conference calls, typically set for 4:30 PM ET after filing quarterly results. Prior scheduling releases in 2024 and 2025 produced modest price moves, mostly positive but one negative, suggesting these are viewed as routine communications rather than major catalysts. This latest Q4 2025 call announcement continues that established pattern ahead of detailed financial disclosures.
Historical Comparison
Past Nephros earnings-call scheduling headlines under the same tag saw average moves of about 0.4%, indicating these announcements have usually been low-volatility, routine events.
The company has maintained a consistent cadence of scheduling quarterly results calls at 4:30 PM ET, reinforcing a stable investor communication pattern around earnings.
Market Pulse Summary
This announcement sets the timetable for Nephros’s Q4 2025 financial results release on March 12, 2026 and the accompanying 4:30pm ET conference call, giving investors a clear date to focus on for fundamental updates. Prior scheduling releases under the same tag have produced small price moves, suggesting they are viewed as routine. Investors may watch how results compare with earlier strong 2025 quarters and monitor any updates on growth initiatives and profitability.
AI-generated analysis. Not financial advice.
SOUTH ORANGE, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth-quarter financial results on Thursday, March 12, 2026 after market close and will host a conference call that same day at 4:30pm ET.
Participants may dial into the call as follows:
Domestic access: 1 (844) 808-7106
International access: 1 (412) 317-5285
Upon joining, please ask to be joined into the Nephros conference call.
An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.
Alternatively, a replay of the call may be accessed until March 19th, 2026, at 1 (855) 669-9658 or
1 (412) 317-0088 for international callers and entering replay access code: 3018234
About Nephros
Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within medical and commercial markets, offering both proactive and emergency solutions for water management.
For more information about Nephros, please visit us at nephros.com.
Investor Relations Contacts:
Kirin Smith, President
PCG Advisory, Inc.
ksmith@pcgadvisory.com
Robert Banks, CEO
Nephros, Inc.
(201) 343-5202 x110
robert.banks@nephros.com
FAQ
When will Nephros (NEPH) release its fourth-quarter 2025 results and hold the conference call?
How can investors join the Nephros (NEPH) conference call on March 12, 2026?
Will there be a replay or audio archive of the Nephros (NEPH) Q4 2025 earnings call?
What replay access code is required for the Nephros (NEPH) Q4 2025 call replay?
